Literature DB >> 17371534

Construction of atorvastatin dose-response relationships using data from a large population-based DNA biobank.

Peggy Peissig1, Ekta Sirohi, Richard L Berg, Christa Brown-Switzer, Nader Ghebranious, Catherine A McCarty, Russell A Wilke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17371534     DOI： 10.1111/j.1742-7843.2006.00035.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN： 1742-7835            Impact factor:   4.080


× No keyword cloud information.
  16 in total

Review 1.  Unravelling the human genome-phenome relationship using phenome-wide association studies.

Authors:  William S Bush; Matthew T Oetjens; Dana C Crawford
Journal:  Nat Rev Genet       Date:  2016-02-15       Impact factor: 53.242

2.  Importance of multi-modal approaches to effectively identify cataract cases from electronic health records.

Authors:  Peggy L Peissig; Luke V Rasmussen; Richard L Berg; James G Linneman; Catherine A McCarty; Carol Waudby; Lin Chen; Joshua C Denny; Russell A Wilke; Jyotishman Pathak; David Carrell; Abel N Kho; Justin B Starren
Journal:  J Am Med Inform Assoc       Date:  2012 Mar-Apr       Impact factor: 4.497

Review 3.  Electronic medical records as a tool in clinical pharmacology: opportunities and challenges.

Authors:  D M Roden; H Xu; J C Denny; R A Wilke
Journal:  Clin Pharmacol Ther       Date:  2012-06       Impact factor: 6.875

4.  The effect of genetic variation in PCSK9 on the LDL-cholesterol response to statin therapy.

Authors:  Q Feng; W Q Wei; C P Chung; R T Levinson; L Bastarache; J C Denny; C M Stein
Journal:  Pharmacogenomics J       Date:  2016-02-23       Impact factor: 3.550

5.  Facilitating pharmacogenetic studies using electronic health records and natural-language processing: a case study of warfarin.

Authors:  Hua Xu; Min Jiang; Matt Oetjens; Erica A Bowton; Andrea H Ramirez; Janina M Jeff; Melissa A Basford; Jill M Pulley; James D Cowan; Xiaoming Wang; Marylyn D Ritchie; Daniel R Masys; Dan M Roden; Dana C Crawford; Joshua C Denny
Journal:  J Am Med Inform Assoc       Date:  2011 Jul-Aug       Impact factor: 4.497

6.  Development of reusable logic for determination of statin exposure-time from electronic health records.

Authors:  Aaron W Miller; Catherine A McCarty; Ulrich Broeckel; Vangelis Hytopoulos; Deanna S Cross
Journal:  J Biomed Inform       Date:  2014-03-15       Impact factor: 6.317

7.  Optimizing drug outcomes through pharmacogenetics: a case for preemptive genotyping.

Authors:  J S Schildcrout; J C Denny; E Bowton; W Gregg; J M Pulley; M A Basford; J D Cowan; H Xu; A H Ramirez; D C Crawford; M D Ritchie; J F Peterson; D R Masys; R A Wilke; D M Roden
Journal:  Clin Pharmacol Ther       Date:  2012-06-27       Impact factor: 6.875

8.  Genetic variation in the UGT1A locus is associated with simvastatin efficacy in a clinical practice setting.

Authors:  Otito F Iwuchukwu; QiPing Feng; Wei-Qi Wei; Lan Jiang; Min Jiang; Hua Xu; Joshua C Denny; Russell A Wilke; Ronald M Krauss; Dan M Roden; C Michael Stein
Journal:  Pharmacogenomics       Date:  2014-11       Impact factor: 2.533

9.  Characterization of statin dose response in electronic medical records.

Authors:  W-Q Wei; Q Feng; L Jiang; M S Waitara; O F Iwuchukwu; D M Roden; M Jiang; H Xu; R M Krauss; J I Rotter; D A Nickerson; R L Davis; R L Berg; P L Peissig; C A McCarty; R A Wilke; J C Denny
Journal:  Clin Pharmacol Ther       Date:  2013-10-04       Impact factor: 6.875

10.  Use of an electronic medical record for the identification of research subjects with diabetes mellitus.

Authors:  Russell A Wilke; Richard L Berg; Peggy Peissig; Terrie Kitchner; Bozana Sijercic; Catherine A McCarty; Daniel J McCarty
Journal:  Clin Med Res       Date:  2007-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.